Vanessa joined Sonoma Biotherapeutics in 2021 with expertise in corporate development, strategic planning and program management.
She was most recently a Senior Associate at Third Rock Ventures, focused on building innovative therapeutic companies and platform technology development. Prior to Third Rock, Vanessa spent 4 years at the Boston Consulting Group, leaving as a Principal in the Healthcare practice with experience across Biopharma, MedTech and Global Health sectors in the US, EU, UK and China. Her projects focused on technology evaluation, corporate development, partnership and growth strategies. Earlier in her career, she was a Technology Analyst at UCSF's Office of Innovation, Technology, and Alliances.
Vanessa earned a Ph.D. in Biochemistry and Molecular Biology from UC San Francisco and a B.A. in Molecular and Cell Biology from UC Berkeley.